Gel reformulated from GlaxoSmithKline mouthwash will be used to fight umbilical cord infections in developing countriesAn antiseptic gel to serve prevent umbilical cord infections in newborn babies,which was developed from a mouthwash, has been given the green light by European regulators.
GlaxoSmithKline developed the product, or called Umbipro,with the charity Save the Children for consume in developing countries. The gel will be sold at a not-for-profit price and could save 422000 lives over five years, according to UN estimates. Related: Born lucky? World Bank reveals life expectancy rates for today's infants Continue reading...
Source: theguardian.com